Paid Clinical Trials Salt Lake City

Discover 716 paid clinical trials in Salt Lake City, Utah. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 716

Observational StudyPancreatic Cancer Early Detection Consortium

Recruiting

Sponsor:

Arbor Research Collaborative for Health

Location:

Salt Lake City UT, Saint George UT, Scottsdale AZ, Phoenix AZshow 39 more

Code:

NCT04970056

Conditions

Pancreas Cancer

Pancreas Cyst

Pancreatic Ductal Adenocarcinoma

Genetic Predisposition

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Investigational CMV Vaccine Study for Volunteers Ages 9–15Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1

PHASE2

Sponsor:

Moderna

Location:

Salt Lake City UT, Idaho Falls ID, Fort Collins CO, Albuquerque NMshow 43 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

AI-081Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors

Recruiting

PHASE1

PHASE2

Sponsor:

OncoC4, Inc.

Location:

Salt Lake City UT, Houston TX, Louisville KY, Ann Arbor MIshow 8 more

Code:

NCT06635785

Conditions

Advanced Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AI-081

Avapritinib with DecitabineAvapritinib With Decitabine in Patients With SM-AHN

Recruiting

PHASE1

Sponsor:

H. Lee Moffitt Cancer Center and Research Institute

Location:

Salt Lake City UT, Phoenix AZ, Palo Alto CA, Ann Arbor MIshow 3 more

Code:

NCT06327685

Conditions

Systemic Mastocytosis With an Associated Hematologic Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Avapritinib

Decitabine

Decitabine/Cedazuridine

BLU-263(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

Recruiting

PHASE2

PHASE3

Sponsor:

Blueprint Medicines Corporation

Location:

Salt Lake City UT, Palo Alto CA, Rochester MN, Houston TXshow 6 more

Code:

NCT04910685

Conditions

Indolent Systemic Mastocytosis

Monoclonal Mast Cell Activation Syndrome

Smoldering Systemic Mastocytosis

Eligibility Criteria

Sex: All

Age: 16+

Healthy Volunteers: Not accepted

Interventions

Elenestinib

Placebo

OfatumumabPharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab

Recruiting

PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Salt Lake City UT, Basalt CO, Los Angeles CA, Fullerton CAshow 20 more

Code:

NCT06869785

Conditions

Relapsing Multiple Sclerosis (RMS)

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Ofatumumab approved dose

Ofatumumab new dose

Observational StudyFetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior

Recruiting

PHASE2

PHASE3

Sponsor:

University of Utah

Location:

Salt Lake City UT, San Francisco CA, Washington DC, Scarborough ME

Code:

NCT05767385

Conditions

Congenital Heart Disease in Children

Hypoxia

Neurodevelopmental Disorders

Complex Congenital Heart Disease

Eligibility Criteria

Sex: Female

Age: 0 - 52

Healthy Volunteers: Not accepted

Interventions

Single Arm

Neonatal Neurobehavioral Scale

Trappsol CycloA 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease

Recruiting

PHASE2

Sponsor:

Cyclo Therapeutics, Inc.

Location:

Salt Lake City UT, Marrero LA, Brooksville FL, Winter Park FLshow 1 more

Code:

NCT05607615

Conditions

Alzheimer's Disease

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

Hydroxypropyl Beta Cyclodextrin

Placebo

VITRAKVIStudy to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body

Recruiting

Sponsor:

Bayer

Location:

Multiple Locations, Salt Lake City UT, Murray UT, Grand Junction COshow 42 more

Code:

NCT04142437

Conditions

Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

larotrectinib(Vitrakvi, BAY2757556)

Dato-DXd & PembrolizumabDatopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

Recruiting

PHASE3

Sponsor:

Daiichi Sankyo

Location:

Salt Lake City UT, Colorado Springs CO, Prescott Valley AZ, Chandler AZshow 32 more

Code:

NCT05555732

Conditions

Metastatic Non Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Datopotamab Deruxtecan

Pembrolizumab

Pemetrexed

Carboplatin

Cisplatin

Vepdegestrant & PF-07220060A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.

Recruiting

PHASE1

PHASE2

Sponsor:

Pfizer

Location:

Salt Lake City UT, West Valley City UT, Fort Collins CO, Loveland COshow 18 more

Code:

NCT06206837

Conditions

Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

vepdegestrant

PF-07220060